Cover Image
市場調查報告書

生命週期經營管理策略:收益最佳化和與學名藥的競爭

Life Cycle Management Strategies - Optimizing revenues and defending generic competition

出版商 CBR Pharma Insights 商品編碼 339642
出版日期 內容資訊 英文 100 Pages
訂單完成後即時交付
價格
Back to Top
生命週期經營管理策略:收益最佳化和與學名藥的競爭 Life Cycle Management Strategies - Optimizing revenues and defending generic competition
出版日期: 2015年07月02日 內容資訊: 英文 100 Pages
簡介

本報告提供生命週期經營管理策略的相關調查、生命週期經營管理和產品生命週期目的與優點、影響等,加上製藥公司的主要策略作為案例研究彙整。

摘要整理

簡介

產品生命週期概要

生命週期經營管理的目的

生命週期經營管理策略的分類和優點

生命週期經營管理的策略籌劃

生命週期經營管理策略的選擇的影響因素

發展策略

  • 適應擴大/定序及重新定位
  • 患者亞族群及個人化醫療
  • 再處方
    • 新的劑型
    • 新的給藥途徑
    • 特殊案例
  • 新用量的優勢與給藥計劃
  • 定量並用和一攬子包裝
  • 下一代產品與修正化學

複合的開發策略方法

商業策略

  • OTC/BTC的轉變
  • 地區的擴大
  • 藥價策略和策略
  • 意識、品牌忠誠、服務程序

法律規章與策略

  • 已經過核准學名藥
  • 對法律上的國防與延遲的負擔
  • 國民的請願
  • 專利期間的延長與市場的壟斷性

醫藥品開發平台和生命週期經營管理

生命週期經營管理策略的有效引進

附錄

目錄
Product Code: GBI059CBR

Summary

GBI Research's latest report, "Life Cycle Management Strategies - Optimizing revenues and defending generic competition" discusses various stages of product lifecycle management (LCM), Developmental, commercial and legal LCM strategies, objectives, benefits, factors impacting the choice of lifecycle management strategies, and keys to successful implementation of the strategies. The report provides detailed case studies for each of the key strategies such as indication expansion, reformulation, fixed-dose combinations, pricing strategies and so on.

Companies mentioned in the report are AbbVie, Actavis, AstraZeneca, Cipla, Gilead, GlaxoSmithKline, Gleevec, Janssen, MannKind, Merck, Novartis, Orexo, Otsuka, Pfizer, Roche, Salix Pharmaceuticals, Sanofi-Aventis, Solvay, Teva and Vifor Pharma.

Scope

  • Introduction of LCM and product life cycle
  • Objectives of LCM and factors impacting the choice of strategies
  • LCM strategies depending on the way of approach
  • Impact of LCM strategies on sales and growth trend of selected products
  • Patent term extension and market exclusivity in the US and Europe
  • LCM strategies of pipeline drugs of key players
  • Keys to successful implementation of LCM strategies

Key Reasons to Purchase

  • Identify the key LCM strategies used by most of the pharmaceutical companies
  • Analyze the strategies to increase lifecycle and revenues of a drug
  • Gain an understanding on the implementation of multiple strategies for a single product by including case studies
  • Understand the operational pipeline strategies of key players

Table of Contents

  • Executive Summary
  • Introduction
  • Overview of Product Life Cycle
  • Product Life Cycle Curve
  • Objectives of Life Cycle Management (LCM)
  • Classification and Benefits of LCM Strategies
  • Strategic Planning for LCM
  • Factors Impacting Choice of LCM Strategies
  • Developmental Strategies
    • Indication Expansion/Sequencing and Repositioning
    • Patient Subpopulations and Personalized Medicine
    • Reformulation
      • New Dosage Forms
      • New Route of Administration
      • Special Cases
    • New Dosage Strengths and Regimen
    • Fixed-Dose Combination and Co-packaging
    • Next Generation Products and Modified Chemistry
      • Metabolites
      • Chiral Switching
      • Polymorphs
  • Multiple Developmental Strategy Approach
  • Commercial Strategies
    • Rx-to-OTC/BTC Switch
    • Geographical Expansion
    • Pricing Strategy and Tactics
      • Pricing Strategy for Targeting Multiple Indications
      • Coupons
      • Co-pay Cards
    • Awareness, Brand Loyalty and Service Programs
  • Regulatory and Legal Strategies
    • Authorized Generics
    • Legal Defense and Pay for Delay
    • Citizen's Petition
    • Patent Term Extension and Market Exclusivity
  • The Pharmaceutical Pipeline and LCM
  • Successful Implementation of LCM Strategies
  • Appendix
Back to Top